Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03152903 |
Recruitment Status :
Active, not recruiting
First Posted : May 15, 2017
Last Update Posted : April 8, 2024
|
Sponsor:
Serum Institute of India Pvt. Ltd.
Information provided by (Responsible Party):
Serum Institute of India Pvt. Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | April 30, 2024 |
Estimated Study Completion Date : | July 30, 2024 |